Ekso Bionics Holdings Inc EKSO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EKSO is a good fit for your portfolio.
News
-
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
-
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
-
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
-
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Trading Information
- Previous Close Price
- $1.28
- Day Range
- $1.17–1.29
- 52-Week Range
- $0.62–3.13
- Bid/Ask
- $1.18 / $1.32
- Market Cap
- $22.38 Mil
- Volume/Avg
- 54,722 / 155,578
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.97
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 72
- Website
- https://www.eksobionics.com
Valuation
|
Metric
|
EKSO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.51 |
Price/Sales | 0.97 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EKSO
|
|---|---|
Quick Ratio | 1.76 |
Current Ratio | 2.49 |
Interest Coverage | −49.32 |
Quick Ratio
EKSO
Profitability
|
Metric
|
EKSO
|
|---|---|
Return on Assets (Normalized) | −38.47% |
Return on Equity (Normalized) | −71.65% |
Return on Invested Capital (Normalized) | −49.93% |
Return on Assets
EKSO
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Qcyghfwrvt | Zsll | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Whrbkpkf | Kwmmwdx | $67.6 Bil | |
ALC
| Alcon Inc | Chdfpgj | Hzjpqs | $39.1 Bil | |
WST
| West Pharmaceutical Services Inc | Swkcykqp | Mwz | $28.6 Bil | |
CLPBY
| Coloplast A/S ADR | Cdnjmrhxg | Qjs | $27.9 Bil | |
RMD
| ResMed Inc | Vmdzdntq | Mnpkjx | $27.0 Bil | |
BAX
| Baxter International Inc | Brzzmqhs | Wybfb | $20.9 Bil | |
COO
| The Cooper Companies Inc | Lhyckfr | Thvpz | $17.9 Bil | |
HOLX
| Hologic Inc | Hpkppzjb | Zqfrpm | $17.8 Bil | |
TFX
| Teleflex Inc | Tmy | Vcdz | $9.9 Bil |